Although we demonstrated here, for the first time, that SHOC2 acts as either an oncogene or a tumor suppressor by differentially regulating the MAPK and mTORC1 signals, using multiple liver cancer cell culture models and two liver tumorigenesis models, our study bears some limitations. The gene discussed is SHOC2; the disease is neoplasm.